Anbio Biotechnology Class A Ordinary Shares

NNNN•United States

Healthcare United States In Vitro & In Vivo Diagnostic Substances

Need professional-grade analysis? Visit stockanalysis.com

$23.19

-1.49%

End of day

Market Cap

N/A

P/E Ratio

0.00

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	-0.68	-0.78	-0.51	2.42	—	0.45
Calmar	—	-2.02	-1.56	-0.87	2.80	—	0.13
Sharpe	—	-0.48	-0.53	-0.31	1.38	—	0.22
Omega	8.35	0.93	0.91	1.07	1.34	—	1.59
Martin	—	-3.36	-2.39	-1.76	6.20	—	0.72
Ulcer	0.86	15.41	34.60	33.20	34.46	—	29.37

Anbio Biotechnology Class A Ordinary Shares (NNNN) Price Performance

Anbio Biotechnology Class A Ordinary Shares (NNNN) trades on United States in USD. The company is classified in the Healthcare sector under the In Vitro & In Vivo Diagnostic Substances industry. The stock currently trades at $23.19, down 1.49% from the previous close.

Over the past year, NNNN has traded between a low of $6.10 and a high of $52.10. The stock has gained 210.2% over this period. It is currently 55.5% below its 52-week high.

Company Info

Sector: Healthcare
Industry: In Vitro & In Vivo Diagnostic Substances
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): $8.19M
EBITDA: N/A
Profit Margin: 28.99%
EPS (TTM): N/A
Book Value: 17.19

Technical Indicators

52 Week High: $55.65
52 Week Low: $5.89
50 Day MA: $26.95
200 Day MA: $31.37
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A